Home » ETF » CHB

CHB - China Biotech Innovation ETF

Stock Price: $17.63 USD 0.53 (3.09%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets $5.99M
NAV $17.10
Expense Ratio 0.65%
PE Ratio 125.18
Beta (5Y) 2.15
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
1-Year Return -
Trading Day April 21
Last Price $17.63
Previous Close $17.10
Change ($) 0.53
Change (%) 3.09%
Day's Open 17.49
Day's Range 17.49 - 17.63
Day's Volume 517
52-Week Range 14.75 - 20.17

Fund Description

The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index (underlying index). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified.

Asset Class
Inception Date
Sep 22, 2020
Ticker Symbol
Index Tracked
Solactive China Biotech Innovation Index

Top 10 Holdings

64.41% of assets
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S2269.HK10.48%
Changchun High and New Technology Industry Group Inc000661.SZ9.35%
Walvax Biotechnology Co Ltd300142.SZ8.04%
Zai LabZLAB7.24%
Shenzhen Kangtai Biological Products Co Ltd A300601.SZ5.80%
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Class A300357.SZ4.62%
Sino Biopharmaceutical Ltd1177.HK4.16%
Pharma Block Sciences (Nanjing) Inc Class A300725.SZ3.85%
BGI Genomics Co Ltd Class A300676.SZ3.82%
View More Holdings


Hide News
  • All
  • Videos
  • Conversation

Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.

Other tickers mentioned: FXH, IEHS, IHI, RYH, SPY, UNH, XLV
2 days ago - Zacks Investment Research

Plus, iShares lowered expense ratios on two of its ETFs.

Other tickers mentioned: AMLP, GOVT, JMUB, USIG, VFLQ
2 weeks ago - ETFcom

Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorP...

Other tickers mentioned: ABBV, RPRX
5 months ago - InvestorPlace

All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their succ...

6 months ago - ETF Trends